The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy
- PMID: 33718235
- PMCID: PMC7947715
- DOI: 10.3389/fonc.2021.640207
The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy
Abstract
Nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV) infection. It is also characterized by heavy infiltration with non-malignant leucocytes. The EBV-encoded latent membrane protein 1 (LMP1) is believed to play an important role in NPC pathogenesis by virtue of its ability to activate multiple cell signaling pathways which collectively promote cell proliferation and survival, angiogenesis, invasiveness, and aerobic glycolysis. LMP1 also affects cell-cell interactions, antigen presentation, and cytokine and chemokine production. Here, we discuss how LMP1 modulates local immune responses that contribute to the establishment of the NPC tumor microenvironment. We also discuss strategies for targeting the LMP1 protein as a novel therapy for EBV-driven malignancies.
Keywords: Epstein-Barr virus; latent membrane protein 1; nasopharyngeal carcinoma; therapy; tumor microenvironment.
Copyright © 2021 Lo, Dawson, Lung, Wong and Young.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.J Pathol. 2015 Oct;237(2):238-48. doi: 10.1002/path.4575. Epub 2015 Aug 3. J Pathol. 2015. PMID: 26096068
-
Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.J Pathol. 2018 Oct;246(2):180-190. doi: 10.1002/path.5130. Epub 2018 Aug 22. J Pathol. 2018. PMID: 29968360 Free PMC article.
-
Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.Oncogene. 2014 Sep 11;33(37):4568-78. doi: 10.1038/onc.2014.32. Epub 2014 Mar 24. Oncogene. 2014. PMID: 24662831 Free PMC article.
-
Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.Cancer Lett. 2013 Aug 28;337(1):1-7. doi: 10.1016/j.canlet.2013.05.018. Epub 2013 May 17. Cancer Lett. 2013. PMID: 23689138 Review.
-
EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.Adv Exp Med Biol. 2017;1018:75-90. doi: 10.1007/978-981-10-5765-6_6. Adv Exp Med Biol. 2017. PMID: 29052133 Review.
Cited by
-
Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses.Infect Agent Cancer. 2022 Nov 28;17(1):58. doi: 10.1186/s13027-022-00471-x. Infect Agent Cancer. 2022. PMID: 36437456 Free PMC article. Review.
-
Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.Front Oncol. 2022 Mar 2;12:840467. doi: 10.3389/fonc.2022.840467. eCollection 2022. Front Oncol. 2022. PMID: 35311066 Free PMC article. Review.
-
Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer.BMC Cancer. 2022 Aug 13;22(1):887. doi: 10.1186/s12885-022-09948-9. BMC Cancer. 2022. PMID: 35963999 Free PMC article.
-
Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):687-696. doi: 10.1158/1055-9965.EPI-22-0452. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36788424 Free PMC article.
-
IRF4 Mediates Immune Evasion to Facilitate EBV Transformation.Viruses. 2025 Jun 24;17(7):885. doi: 10.3390/v17070885. Viruses. 2025. PMID: 40733503 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials